medigraphic.com

2006, Number 3

<< Back Next >>

Anales de Radiología México 2006; 5 (3)

Secondary complications to Juvenile Nasopharyngeal Angiofibroma embolization. Findings in 66 cases

Navarro MRM, Guerrero AGML, Chavolla MR, Rodriguez BRA, Flores MJF

Language: Spanish
References: 47
Page: 231-238
PDF size: 162.17 Kb.


ABSTRACT

Introduction: With the increase in the procedures of endovascular therapy, increase in the complications inherent thereto, has also been reported. The pre-surgical embolization has been especially useful in Juvenile Nasopharyngeal Angiofibroma (JNA). We have reported a bigger incidence of these procedures. Complications presented may range from mild, moderate and severe. Among those occurring most often are: post-embolization pain, arterial transitory spasm, temporary facial nerve paralysis, undesirable embolism, arterial rupture and the loss of vision.
Material and Methods: 66 files of patients submitted to pre-surgical embolization of JNA were reviewed. Patients came from of the Otolaryngology Service from HGM (Mexico General Hospital) and CMN 20 de Noviembre ISSSTE (National Medical Center) to determine in how many of the patients, further complications to the embolization were reported and to describe what type.
Results: From a total of 66 files, in an equal number of patients, complications inherent to the embolization procedure were reported.
Conclusions and Discussion: The results reported in our series, are similar to those reported in the world literature, not bigger to 5% of the embolization. For such a reason, we recommend widely, a pre-surgical embolization to ease surgical resection.


REFERENCES

  1. Guerrero AG. Angiofibroma juvenil de nasofaringe. Experiencia en dos Hospitales de concentración. Anales de Radiología México 2002, 2: 403-407.

  2. Harnsberger. Serie Radiología Clinica Cabeza y Cuello. 1ª. Ed. Elsevier; 2004, p. 159-61.

  3. Berger SB, Chaloupka JC, Putman CM, Citardi MJ, Lamb T, Hypervascular tumor of the buccal space in an adult as a late recurrence of juvenile angiofibroma. Am J Neuroradiol 1996; 17(7): 1384-7.

  4. Nagai MA, Butugan O, Logullo A, Brentani MM. Expression of growth factors, protooncogenes and p53 in nasopharyngeal angiofibromas. Laryngoscope 1996; 106: 190-5

  5. Francis MG. Angiofibroma and adenomatous polyposis. Gasroenterology 1993; 105: 1550-2.

  6. Francois M. Epistaxis in children. Arch Pediatr 1996; 3(8): 806-13.

  7. Duval AJ, Moreano A. Juvenile nasopharyngeal angiofibroma: Diagnosis and treatment. Otolaryngol Head and Neck Surg 1987; 97: 534-40.

  8. Froedberg SA. Vascular fibroma of the nasopharynx. Arch Otolaryngol Head and Neck Surg 1996; 122.

  9. Sessions RB, Bryan RN, Naclerio RM, et al. Radiographic staging of Juvenile angiofibroma. Head Neck Surg 1981; 3: 279-83.

  10. Fisch Ugo. The infratemporal fossa approach for nasopharyngeal tumors. Laryngoscope 1983; 93: 36-44.

  11. Chandler JR, Goulding R, Moskowitz L, et al. Nasopharyngeal angiofibroma: Staging and management. Ann Otol Rhinol Laryngol 1984; 93: 322-29.

  12. Girgis IH, Fahmy SA. Nasopharingeal fibroma, its histopatological features. J Laryngol; 7: 1107

  13. Gates GA, Rice DH, Koopman CF, et al. Flutamine induced regression of angiofibroma. Laryngoscope 1992; 102(6): 641-4.

  14. Shinkwin CA. Evaluation of Surgicel Nu-knit, Merocel and Vasolene gauze nasal packs: a randomized trial. Rhinology 1996; 34(1): 41-3.

  15. Ghosh A, Jackson R. Cautery or cream for epistaxis in children. Emer Med J 2001; 18(3): 210.

  16. Emanuel JM. Epistaxis. Cummings, Otolaryngology Head & Neck Surgery. Mosby 1999.

  17. Shinkwin CA. Evaluation of Surgicel Nu-knit, Merocel and Vasolene gauze nasal packs: a randomized trial. Rhinology 1996; 34(1): 41-3.

  18. Pringle MB. The use of Merocel nasal packs in the treatment of epistaxis. J Laryngol Otol 1996; 110(6): 543-6.

  19. Taxy JB, Juvenile Nasopharingeal Angiofibroma: An ultrastructural study. Cancer 39: 1044.

  20. Mcleod RMJ. Estrogen receptor in nasopharyngeal angiofibromas. Laryngoscope; 90: 630-4.

  21. Garcia CE, Ruffenacht D, Thoerl C, et al. Preoperative embolization of nasopharyngeal angiofibroma. Report of 58 cases. Neiroradiology 1988; 30: 556-60.

  22. Djindjian R, Merland JJ. Superselective arteriography of external carotid artery. Berlin, Germany; Springer; 1978.

  23. Roberson GH, Price AC, Davis JM, Gulati A. Therapeutic embolization of juvenile Angiofibroma. AJR 1979; 133: 657-63.

  24. Macdaniel RK. Nasopharyngeal angiofibroma: With lateral extension into the cheek. J Oral Maxilofacial Surg 1995; 53: 473-6.

  25. Biller HF, Sessions DG, Ogura JH, Angiofibromas: A treatment aproach. Laryngoscope 84: 171-6.

  26. Brenner JW, Neel HB, Desanto, Jones GC. Angiofibroma: teatment trends in 150 patientes during 40 years. Laryngoscope 1986; 96: 1321-9.

  27. Drouet L. Oestrogénes androgénes et vaisseaux. Quot Med; (Supp1. 2150)2: 16-31.

  28. Neel HB, Whicker JH, Devine KD, Juvenile Angiofibroma: review of 120 cases: Am J Surg 1973; 126: 547-56.

  29. Brown J. Surgical treatment of Juvenile Nasopharingeal Angiofibroma. Ann Otol Rhinol Laryngol; 56: 294-7.

  30. Batsakis JG, Klopp CT, Newman W. Fibrosarcoma arising in a Juvenile Nasopharingeal Angiofibroma following extensive radiation therapy. Am J Surg; 21: 786.

  31. Walike JW, Mackay B. Nasopharingeal Angiofibroma: light and electron microscopic changes after stilbestrol therapy. Laryngoscope 1970; 80: 1109.

  32. Goncalves CG, Briant DR. Radiologic findings in Juvenile Nasopharingeal Angiofibroma. Radiol 29: 209-15.

  33. Sorimachi. Embolization of cerebral arteriovenous malformations acjieved with polyvinyl alcohol particles: angiographic reappearance and complications. AJNR Am J Neeuroradiol 1999; 20: 1323-8.

  34. Guerrero AG, Ramos MPL, Perez MJA. Pasta de GEORAM: Material embolizante permanente. Experiencia en el HGM. Rev Mex Radiol 1996.

  35. Las Jaunias P. Nasal angiofibroma, hazards in embolization. Radiology 1980; 136: 119-23.

  36. Cox RH, Fisher GM. Effects of sex Hormones on the passive mechanical properties of rat carotid artery. Blood vessels; 15: 266-76.

  37. Martin H, Ehrlich He, Abels JC. Juvenile Nasopharingeal Angiofibroma. Am Surg; 84(127): 513-36.

  38. Osborne DA, So-calles Juvenile Nasopharingeal Angiofibroma. J Laryngol Otol; 73: 295-316.

  39. Suodoba DJ, Kirschner. Ultrastructure of nasopharyngeal angiofibroma. Cancer 19: 1949.

  40. Friedman I, Osborn DA. Systemic Pathology. 2nd ed. Vol 1. Edinburg: Churchill Livingstone; p. 228-30.

  41. Maurice M, Milad M. Pathogenesis of Juvenile Nasopharingeal Angiofibroma (a new concept) J Laryng Otol 95: 1121-6.

  42. Casasco. Major complicatios of percutaneous embolization of Skull-Base Tumors. American Journal of Neuroradiology 1999; 20: 179-81.

  43. Davis KR. Embolization of ephistaxis in AJN. AJNR 1986; 5: 953-67.

  44. Kubba H, MacAndie C. A prospective, single-blind, randomized controlled trial of antiseptic cream for recurrent epistaxis in childhood. Clin Otolaryngol 2001 Dec; 26(6): 465-8.

  45. Toppozada H, Micheals L. Human nasal mucosal in the menstrual cicle. J Laryng Otol; 95: 1237-7.

  46. Schiff M. Juvenile nasopharyngeal angiofibroma: A theory of phatogenesis. Laryngoscope 1959; 69: 981-1016.

  47. Guerrero AG, Ortiz MG, Martínez RL, Cárdenas FF, Ramos PL, Navarro MR.Aplicaciones de la Radiología Intervencionista en cabeza y cuello. Anales de Radiología México 2005, 1: 39-46.




2020     |     www.medigraphic.com